EZElisa™鳞状细胞癌抗原1/2（SCCA 1/SCCA
2）试剂盒-EZElisa™ Squamous Cell Carcinoma Antigen 1/2 (SCCA1/SCCA2) Kit- 询价
- Biogradetech
- 美国
- A-QEK01046-96wells
- 2025年07月13日
企业认证
相关产品推荐更多 >
EZElisa™ Connexin 26（CX26）试剂盒-EZElisa™ Connexin 26 (CX26) Kit
询价
EZElisa™可溶性内皮素（sE-seLectin）ELISA试剂盒-EZElisa™ Soluble Endothelium-seLectin (sE-seLectin) ELISA Kit
询价
EZElisa™小鼠晚期糖基化终产物受体（AGEs）ELISA试剂盒-EZElisa™ Mouse Receptor For Advanced Glycation Endproducts (RAGE) ELISA Kit
询价
变ADRENALINE血浆ELISA快速检测（RUO）试剂盒-Metanephrine Plasma ELISA Fast Track (RUO) Kit
询价
EZElisa™人癌蛋白诱导转录本3（OIT3）ELISA试剂盒-EZElisa™ Human Oncoprotein Induced Transcript 3 (OIT3) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Squamous Cell Carcinoma Antigen 1/2 (SCCA1/SCCA2) Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™鳞状细胞癌抗原1/2（SCCA 1/SCCA 2）试剂盒，EZElisa™ Squamous Cell Carcinoma Antigen 1/2 (SCCA1/SCCA2) Kit，鳞状细胞癌抗原1/2（SCCA 1/SCCA 2）试剂盒, Squamous Cell Carcinoma Antigen 1/2 (SCCA1/SCCA2) Kit
产品名称：EZElisa™含SCAN结构域的蛋白3（SCAND3）试剂盒-EZElisa™ Squamous Cell Carcinoma Antigen 1/2 (SCCA1/SCCA2) Kit
产品货号：A-QEK01046-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of EZElisa™ Squamous Cell Carcinoma Antigen 1/2 (SCCA1/SCCA2) in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：78 - 5,000 pg/ml
该EZElisa™鳞状细胞癌抗原1/2（SCCA 1/SCCA 2）试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™含SCAN结构域的蛋白3（SCAND3）试剂盒-EZElisa™ Squamous Cell Carcinoma Antigen 1/2 (SCCA1/SCCA2) Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Isolation and Culture of Squamous Cell Carcinoma Lines
Cutaneous squamous cell carcinoma (SCC) keratinocytes readily grow, expand in culture, and continuously passage, suggesting either spontaneous immortalisation at the early stage of culture or inherent proliferative capacity. One feature
Epigenome and DNA Methylation in Oral Squamous Cell Carcinoma
in epigenetic changes includes the posttranslational modifications of histones, mainly phosphorylation, deacetylation changes, and in the ubiquitinylation status. Oral squamous cell carcinoma is the most common malignancy of the oral cavity, and epigenetic
Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
isolated based on the presence of specific cell surface antigens. In head and neck squamous cell carcinomas, we have shown that the CSCs are contained within the CD44+ subset of tumor cells. This subset contains cells capable of initiating tumor growth
技术资料暂无技术资料 索取技术资料
